Optimizing Busulfan Dosing in Myeloablative Conditioning Regimens in Patients Undergoing Allogeneic Stem Cell Transplant

Key Points

• Busulfan dosing adjustments reduce toxicity in myeloablative conditioning protocols for stem cell transplants.
• In targeted populations, optimal dosing led to a significant reduction in post-transplant complications.
• The pharmacokinetic analysis utilized data from multiple treatment centers over three years to refine dosing guidelines.
• Optimizing dosing strategies may enhance patient safety and treatment success during stem cell transplant procedures.